NEW YORK – The European Medicines Agency's Committee for Medicinal Products for Human Use recommended approval of Autolus Therapeutics' autologous CD19-directed CAR T-cell therapy Aucatzyl ...

A TikTok post for the "McMigraine" remedy -- Coca-Cola and a large order of fries -- caused some people to rush to McDonald's for headache relief, but this combination is not a cure or an effective ...

AstraZeneca wins CHMP nod for Imfinzi combo in muscle-invasive bladder cancer, based on data from the phase III NIAGARA study ...

Tevimbra is currently approved in the EU as a treatment for gastric cancer, esophageal squamous cell cancer and small cell ...

BeiGene's Tevimbra gets a highly sought after recommendation.

AstraZeneca (AZN) stock in focus as its antibody drug Imfinzi gains EU panel support for treating muscle-invasive bladder ...

Chemotherapy has been the standard treatment for metastatic NPC; however, distant metastasis continues to be a significant cause of treatment failure and death, making new treatment options essential, ...

Discover the key biotech trends moving the industry forward in Europe at a time when there lies uncertainty in global ...

(Alliance News) - AstraZeneca PLC on Tuesday said its Imfinzi, or durvalumab, therapy has been recommended for approval in the EU for the treatment of muscle-invasive bladder cancer.

Committee for Medicinal Products for Human Use (CHMP) has rendered a positive opinion recommending approval for the Blenrep ...

The relentless hunger and associated behaviours significantly impact the quality of life for those with Prader-Willi syndrome ...

The two active substances are antivirals that inhibit HIV reverse transcriptase through incorporation into the viral DNA, ...